ADACEL injection suspension medication leaflet

J07AJ52 • diphtheria + tetanus vaccine + acellular pertussis • Antiinfectives for systemic use | Bacterial vaccines | Pertussis vaccines

The diphtheria, tetanus, acellular pertussis (DTPa) vaccine is used to prevent diphtheria, tetanus, and whooping cough (pertussis), three serious infectious diseases caused by bacteria. Unlike the whole-cell pertussis vaccine, the DTPa vaccine contains purified components of Bordetella pertussis, which reduces the risk of adverse reactions and makes it better tolerated, especially by children.

The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. Booster doses are required at regular intervals to maintain immunity.

Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.

The DTPa vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.